# FDA 483 - Aurobindo Pharma USA Inc - June 15, 2024

Source: https://www.keypedia.com/records/483/aurobindo-pharma-usa-inc/bd6c21d0-cf5a-478a-b0e5-d85571f30522

> FDA 483 for Aurobindo Pharma USA Inc on June 15, 2024. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Aurobindo Pharma USA Inc
- Inspection Date: 2024-06-15
- Product Type: other
- Office Name: Office of the Commissioner
- Summary: The provided document content is incomplete, consisting solely of page number references without the actual text of the FDA 483 inspection report. Consequently, essential details such as the company name, specific inspection dates, identified violations or issues, the applicable regulatory framework, and any required corrective actions cannot be extracted or summarized. To provide a comprehensive and accurate summary as requested, the complete content of the FDA 483 document is necessary.

## Related Documents

- [483 - 2024-05-13](https://www.keypedia.com/records/483/aurobindo-pharma-usa-inc/23d87088-0c57-415a-b47d-edecbaeb8f2b)
- [483 - 2024-05-15](https://www.keypedia.com/records/483/aurobindo-pharma-usa-inc/51f91a8f-0ef6-4350-95ac-a9a7c46f8d32)
- [483 - 2025-05-15](https://www.keypedia.com/records/483/aurobindo-pharma-usa-inc/5f846bc0-d7ea-4e9a-9d63-fae85c1032c6)

## Related Officers

- [Drug Investigator](https://www.keypedia.com/people/samir-c-gala/904c34ee-013d-4663-a87a-9cbdbcf2b40e)

Company: https://www.keypedia.com/companies/aurobindo-pharma-usa-inc/a8dbf5ca-1af1-432a-85b6-5a0c7499eaa5

Office: https://www.keypedia.com/offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424